At MIT, Nobel laureate Frances Arnold describes innovation by evolution
In the Hoyt C. Hottel Lecture, Arnold tells the story of her pathbreaking research to engineer better enzymes for critical applications.
Six with MIT ties elected to the National Academy of Medicine for 2021
Professors Linda Griffith and Feng Zhang along with Guillermo Ameer ScD ’99, Darrell Gaskin SM ’87, William Hahn, and Vamsi Mootha recognized for contributions to medicine, health care, and public health.
How diet affects tumors
A new study finds cutting off cells’ supplies of lipids can slow the growth of tumors in mice.
New cancer treatment may reawaken the immune system
By combining chemotherapy, tumor injury, and immunotherapy, researchers show that the immune system can be re-engaged to destroy tumors in mice.
Study shows fragile X treatment can incur resistance, suggests ways around it
While the brain acquires resistance to continuous treatment with mGluR5 inhibitor drugs, lasting effects may still arise if dosing occurs intermittently and during a developmental-critical period.
Putting artificial intelligence at the heart of health care — with help from MIT
Cardiologist Demilade Adedinsewo is using her MIT Professional Education experience to advance cardiovascular care at the Mayo Clinic.
Enabling AI-driven health advances without sacrificing patient privacy
Secure AI Labs, founded by alumna Anne Kim and MIT Professor Manolis Kellis, anonymizes data for AI researchers.
Weighing cancer cells to personalize drug choices
A new study shows a link between patient survival and changes in tumor cell mass after glioblastoma treatment.
Using AI and old reports to understand new medical images
Scientists employ an underused resource — radiology reports that accompany medical images — to improve the interpretive abilities of machine learning algorithms.
Deep learning helps predict new drug combinations to fight Covid-19
Neural network identifies synergistic drug blends for treating viruses like SARS-CoV-2.
Toward a smarter electronic health record
An AI-enhanced system enables doctors to spend less time searching for clinical information and more time treating patients.
Statistical model defines ketamine anesthesia’s effects on the brain
Neuroscientists at MIT and Massachusetts General Hospital develop a statistical framework that describes brain-state changes patients experience under ketamine-induced anesthesia.
Chemical engineering meets cancer immunotherapy
Sachin Bhagchandani wins NCI Predoctoral to Postdoctoral Fellow Transition (F99/K00) Award.
Biologists identify new targets for cancer vaccines
Vaccinating against certain proteins found on cancer cells could help to enhance the T cell response to tumors.
Landmark Bio, a biomanufacturing facility co-founded by MIT, breaks ground in Watertown Arsenal
Public-private partnership aims to advance development and production of medical treatments.